Cargando…
Fecal Galectin-3: A New Promising Biomarker for Severity and Progression of Colorectal Carcinoma
BACKGROUND AND OBJECTIVES: The aim of the study was to determine systemic and fecal values of galectin-3 and pro- and anti-inflammatory cytokines in patients with CRC and the relationship with clinicopathological aspects. METHODS: Concentrations of galectin-3, TNF-α, TGF-β, IL-10, and IL-1β were ana...
Autores principales: | Jovanovic, Milan, Gajovic, Nevena, Zdravkovic, Natasa, Jovanovic, Marina, Jurisevic, Milena, Vojvodic, Danilo, Maric, Veljko, Arsenijevic, Aleksandar, Jovanovic, Ivan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5904774/ https://www.ncbi.nlm.nih.gov/pubmed/29849497 http://dx.doi.org/10.1155/2018/8031328 |
Ejemplares similares
-
Anemia of inflammation in patients with colorectal cancer: Correlation with interleukin-1, interleukin-33 and galectin-1
por: Jocić, Miodrag, et al.
Publicado: (2022) -
Metabolic syndrome attenuates ulcerative colitis: Correlation with interleukin-10 and galectin-3 expression
por: Jovanovic, Marina, et al.
Publicado: (2019) -
Galectin-3 as an important prognostic marker for COVID-19 severity
por: Gajovic, Nevena, et al.
Publicado: (2023) -
Potential Hepatoprotective Role of Galectin-3 during HCV Infection in End-Stage Renal Disease Patients
por: Lukic, Ruzica, et al.
Publicado: (2017) -
Galectin-1 as the new player in staging and prognosis of COVID-19
por: Markovic, Sofija Sekulic, et al.
Publicado: (2022)